Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Wearable sensors provide early detection of progression in Parkinson’s Disease

A team of researchers from the University of Oxford has shown for the first time that it is possible to track the progression of Parkinson’s Disease accurately using specially trained machine learning algorithms to analyse data derived from sensor devices worn by patients.

A black women doctor at the consultation with and old man © Shutterstock

The novel methods described in this study led by Professor Chrystalina Antoniades in Oxford's Nuffield Department of Clinical Neurosciences can be used by clinicians alongside the more traditional clinical rating scales to not only improve the accuracy of diagnosis, but also track progression of Parkinson's Disease.

Being able to monitor the progression of motor symptoms in people with neurological disorders such as Parkinson's disease is important for two main reasons: clinicians need to be confident in their assessment of how the disease is progressing in individual patients, and researchers running clinical trials need to be able to measure how well therapeutic interventions are working.

 

Read the full story on the University of Oxford's website.

Similar stories

The Nuffield Department of Women's & Reproductive Health's Clinical Research Group recruits its 2,000th participant to the Generation Study

Oxford’s Clinical Research Group (CRG) has reached an important milestone after recruiting its 2,000th participant to the nationwide Generation Study.

Dementias Platform UK (DPUK) blood biomarker project takes next step towards NHS dementia diagnosis

A project involving researchers from the Universities of Oxford and Cambridge, Imperial College London and Dementias Platform UK (DPUK) has been selected for a major UK initiative aimed at improving dementia diagnosis and helping more people access the support and treatment they need sooner.

Robotic hip and knee surgery fails to cut overall risk of repeat surgery

Two major studies from the University of Oxford, Queen Mary University of London and the University of Bristol, have found that robotic-assisted hip and knee replacement does not reduce the overall early risk of repeat surgery compared with conventional surgery.

Oxford medical student takes AI safety message to the Palace of Versailles

Oxford medical student Julian Shellard has presented at an international workshop on the future of Artificial Intelligence (AI) at the Palace of Versailles in Paris, highlighting the important role medical students can play in global conversations on shaping the future of science and medicine.

Everyday DNA damage reveals a hidden weakness in some cancers

Researchers in the Chapman Group at the MRC Weatherall Institute of Molecular Medicine, have discovered why cancer cells lacking a protein called ATM are particularly vulnerable to a class of cancer drugs known as PARP inhibitors, solving a scientific puzzle that has challenged researchers for nearly 20 years.

Dunn School publishes new children’s book to mark centenary

The collaboration with Oxford University Press brings the story of the development of Penicillin to a new audience